These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8578542)

  • 1. D-Dimer in intra-uterine growth retardation and gestational hypertension.
    Francalanci I; Comeglio P; Liotta AA; Cellai AP; Fedi S; Parretti E; Mello G; Prisco D; Abbate R
    Thromb Res; 1995 Oct; 80(1):89-92. PubMed ID: 8578542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of antenatal D-dimer and fibrinogen with postpartum hemorrhage and intrauterine growth restriction in preeclampsia.
    Shao H; Gao S; Dai D; Zhao X; Hua Y; Yu H
    BMC Pregnancy Childbirth; 2021 Sep; 21(1):605. PubMed ID: 34482843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal plasma D-dimer levels in normal and complicated pregnancies.
    Nolan TE; Smith RP; Devoe LD
    Obstet Gynecol; 1993 Feb; 81(2):235-8. PubMed ID: 8423957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
    Laskowska M; Laskowska K; Oleszczuk J
    J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolytic response to venous occlusion and fibrin fragment D-dimer levels in normal and complicated pregnancy.
    Ballegeer V; Mombaerts P; Declerck PJ; Spitz B; Van Assche FA; Collen D
    Thromb Haemost; 1987 Dec; 58(4):1030-2. PubMed ID: 3445223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of plasma D-dimer in patients with pregnancy induced hypertension].
    Zhou H; Chen R; Liu X
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jun; 32(6):347-9. PubMed ID: 9596914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood viscosity and haemostatic factors in late pregnancy, pre-eclampsia and fetal growth retardation.
    Thorburn J; Drummond MM; Whigham KA; Lowe GD; Forbes CD; Prentice CR; Whitfield CR
    Br J Obstet Gynaecol; 1982 Feb; 89(2):117-22. PubMed ID: 7066243
    [No Abstract]   [Full Text] [Related]  

  • 8. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
    Wathén KA; Tuutti E; Stenman UH; Alfthan H; Halmesmäki E; Finne P; Ylikorkala O; Vuorela P
    J Clin Endocrinol Metab; 2006 Jan; 91(1):180-4. PubMed ID: 16263826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
    Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
    BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are the maternal and umbilical VEGF-A and SVEGF-R1 altered in pregnancies complicated by preeclampsia with or without intrauterine foetal growth retardation? Preliminary communication.
    Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
    Med Wieku Rozwoj; 2008; 12(1):499-506. PubMed ID: 18663270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrin-fibrinogen degradation products and pregnancy-specific beta 1-glycoprotein (SP 1) in normal and pathological pregnancies].
    Geyer H; Nothnagel D
    Geburtshilfe Frauenheilkd; 1984 Dec; 44(12):787-91. PubMed ID: 6335446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of maternal plasma HTRA1 level in preeclampsia complicated by IUGR.
    Marzioni D; Lorenzi T; Altobelli E; Giannubilo SR; Paolinelli F; Tersigni C; Crescimanno C; Monsurrò V; Tranquilli AL; Di Simone N; Castellucci M
    Placenta; 2012 Dec; 33(12):1036-8. PubMed ID: 23083999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma D-dimer levels in preeclampsia].
    Manolov V; Marinov B; Masseva A; Vasilev V
    Akush Ginekol (Sofiia); 2014; 53 Suppl 2():15-8. PubMed ID: 25510047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation.
    Wathén KA; Ylikorkala O; Andersson S; Alfthan H; Stenman UH; Vuorela P
    Acta Obstet Gynecol Scand; 2009; 88(5):593-8. PubMed ID: 19308751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of D-dimer as a marker for severity in pregnancies with preeclampsia].
    Marcq G; Beaugrand Dubart L; Tournoys A; Subtil D; Deruelle P
    Gynecol Obstet Fertil; 2014 Jun; 42(6):393-8. PubMed ID: 23099029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of fibrin(ogen) degradation products in preeclampsia using immunoblot, enzyme-linked immunosorbent assay, and latex-based agglutination.
    Proietti AB; Johnson MJ; Proietti FA; Repke JT; Bell WR
    Obstet Gynecol; 1991 May; 77(5):696-700. PubMed ID: 2014082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-D dimers: a poor correlate of PPIH and subsequent outcomes.
    Royle G; Barry CL; Blacklock H; Lake Y
    Int J Gynaecol Obstet; 1998 Jul; 62(1):37-42. PubMed ID: 9722123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction.
    Schlembach D; Wallner W; Sengenberger R; Stiegler E; Mörtl M; Beckmann MW; Lang U
    Ultrasound Obstet Gynecol; 2007 Apr; 29(4):407-13. PubMed ID: 17330322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-dimer plasma levels during normal pregnancy measured by specific ELISA.
    Francalanci I; Comeglio P; Alessandrello Liotta A; Cellai AP; Fedi S; Parretti E; Mecacci F; Mello G; Prisco D; Abbate R
    Int J Clin Lab Res; 1997; 27(1):65-7. PubMed ID: 9144030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of placental growth factor and uterine artery doppler pulsatility index in pregnancies involving intrauterine fetal growth restriction or preeclampsia to predict perinatal outcomes.
    Gomez-Roig MD; Mazarico E; Sabria J; Parra J; Oton L; Vela A
    Gynecol Obstet Invest; 2015; 80(2):99-105. PubMed ID: 25924544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.